Rahul Kamdar

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Illuminating T cell-dendritic cell interactions in vivo by FlAsHing antigens”.

Illuminating T cell-dendritic cell interactions in vivo by FlAsHing antigens

eLife(2023)10.7554/elife.91809

N/A

0.165DataRank · unranked

2 citations

Jafar Al Souz, Daniel Williams, Rahul Kamdar, Olena Kamenyeva, Juraj Kabát +3 more

UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.07.509566

N/A

0DataRank · unranked

2 citations

Rahul Kamdar, Franklin Ning, Soumya Korrapati, Michael W. Caminear, Lídia Hernandez +18 more

UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer

Journal of Experimental & Clinical Cancer Research(2023)10.1186/s13046-023-02820-z

N/A

0DataRank · unranked

15 citations

Rahul Kamdar, Franklin Ning, Soumya Korrapati, Michael W. Caminear, Lídia Hernandez +18 more

Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells

Frontiers in Oncology(2022)10.3389/fonc.2022.762820

N/A

0DataRank · unranked

26 citations

Brittney S. Harrington, Rahul Kamdar, Michael J. Kruhlak, Christina M. Annunziata, Michael W. Caminear

Targeting Metabolic Vulnerability by Combining NAMPT Inhibitors and Disulfiram for Treatment of Recurrent Ovarian Cancer

Research Square(2024)10.21203/rs.3.rs-4150814/v1

N/A

0DataRank · unranked

0 citations

Kei Kudo, Daniel R. Crooks, Yoshimi Endo Greer, Ye Yang, Jeffrey Brender +10 more

Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancer

Cell Death and Disease(2025)10.1038/s41419-025-07672-3

N/A

0DataRank · unranked

4 citations

Yoshimi Endo Greer, Daniel R. Crooks, Ye Yang, Jeffrey Brender, Teruhiko Yoshida +10 more

NF-κB Signaling Modulates miR-452-5p and miR-335-5p Expression to Functionally Decrease Epithelial Ovarian Cancer Progression in Tumor-Initiating Cells

International Journal of Molecular Sciences(2023)10.3390/ijms24097826

N/A

0DataRank · unranked

8 citations

Brittney S. Harrington, Emma Attar, Soumya Korrapati, Jyoti Shetty, Yongmei Zhao +5 more